Extracellular protein substrates

Extracellular protein substrates encompass a vast and diverse array of proteins located outside the cell membrane, including components of the extracellular matrix (ECM), secreted signaling molecules, and circulating plasma proteins (1.1.4, 1.2.1). These proteins are essential for maintaining tissue architecture, mediating intercellular communication, and regulating physiological processes such as blood coagulation and immune responses (1.1.2, 1.2.2). In many pathological conditions, specific extracellular proteins become dysregulated, leading to issues like excessive tissue scarring (fibrosis), the formation of toxic aggregates such as beta-amyloid in Alzheimer's disease, or the overproduction of inflammatory cytokines (1.1.4, 1.2.4). While many therapeutic strategies, such as monoclonal antibodies and Lysosome-Targeting Chimeras (LYTACs), are designed to bind or degrade specific extracellular proteins, the term "Extracellular protein substrates" itself refers to a functional category rather than a single, discrete therapeutic target (1.1.1, 1.1.3). Drugs targeting this class often focus on inhibiting the enzymes that modify these substrates, such as matrix metalloproteinases, or utilizing degradation pathways to remove pathogenic proteins from the extracellular environment (1.1.1, 1.2.1). Consequently, this term lacks the specificity required for standard drug-target interaction profiles and is typically used in the context of enzymatic activity or degradation technologies.

Other names

Extracellular proteinsSecreted proteinsCirculating proteinsExtracellular matrix proteins

N/A